OpGen Competitors and Similar CompaniesClear all
OpGen's competitors and similar companies include DiaSorin and Sequence Bio.
 OpGen OpGen focuses on commercializing solutions for DNA analysis and genomics with the Argus whole genome mapping system and MapIt services. |  DiaSorin DiaSorin is a company that develops, produces, and commercializes reagent kits and instruments for diagnosis and research. |  Sequence Bio Sequence Bio is a biotechnology company committed to improving how people treat diseases and develop medicines. | |
Founding Date | Founding Date 2002 | Founding Date 1968 | Founding Date 2013 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Gaithersburg, US HQ Wien, AT Holzgerlingen, DE Rockville, US | Locations Saluggia, IT HQ Macquarie Park, AU Wien, AT Anderlecht, BE San Paolo, BR Mississauga, CA Shanghai, CN see more | Locations St. John's, CA HQ |
Employees | Employees 4426% increase | Employees 3,249 | Employees 185% decrease |
Valuation ($) | Valuation ($) 14.9 m | Valuation ($) 6.1 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $30.2m (FY, 2025) | Revenue (est.) €1.2b (FY, 2025) | Revenue (est.) N/A |
Net income | Net income $23.6m (FY, 2025) | Net income €150m (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 78.8m | Total funding raised N/A | Total funding raised $ 4m |
For sources of this data, please see the company profile
View Company Profiles
DiaSorin
HQ
Saluggia, IT
Employees
3,249
DiaSorin is a company that develops, produces, and commercializes reagent kits and instruments for diagnosis and research.
View companySequence Bio
HQ
St. John's, CA
Employees
18↓ 5% decrease
Sequence Bio is a biotechnology company committed to improving how people treat diseases and develop medicines.
View company